J Am Pharm Assoc (2003). 2021 Jan-Feb;61(1):e93-e98. doi: 10.1016/j.japh.2020.04.020. Epub 2020 May 26.
Instruct clinicians on counterfeit drugs and their implications for patient health. Counterfeit drugs imperil patients around the globe, and their penetration into the United States, Canada, and Western Europe is only increasing over time. In addition to inserting counterfeit drugs in the legitimate drug supply, rogue Internet pharmacies and consumer purchases while traveling abroad allow counterfeit drugs to endanger patients. Pharmacists need to understand the nature and severity of the issue and directly counter it through personal actions to secure a legitimate drug supply, such as by using verified distributors and examining the shipment packaging, product packaging, the bottle, and the label for evidence to determine if it is counterfeit or has been tampered with. They can also indirectly counter it through patient education and by working with other key stakeholders in the health care system. Given the risk to patients, pharmacists have an important role to play in limiting patient use of counterfeit drugs.
指导临床医生识别假药及其对患者健康的影响。假药在全球范围内威胁着患者的安全,而且随着时间的推移,它们不断渗透到美国、加拿大和西欧。除了在合法药品供应中混入假药之外,不良互联网药店和消费者在国外旅行时的购买行为也使假药危及患者。药剂师需要了解这一问题的性质和严重程度,并通过个人行动直接抵制,以确保合法药品的供应,例如通过使用经过验证的分销商,并检查药品包装、产品包装、瓶子和标签,以确定其是否为假药或是否被篡改。他们还可以通过患者教育和与医疗保健系统中的其他关键利益相关者合作来间接地抵制假药。鉴于对患者的风险,药剂师在限制患者使用假药方面发挥着重要作用。